A novel inhalable nanobody targeting IL-4Rα for the treatment of asthma.
Zhu M, Ma L, Zhong P, Huang J, Gai J, Li G, Li Y, Qiao P, Gu H, Li X, Yin Y, Zhang L, Deng Z, Sun B, Chen Z, Ding Y, Wan Y.
Zhu M, et al. Among authors: zhong p.
J Allergy Clin Immunol. 2024 Oct;154(4):1008-1021. doi: 10.1016/j.jaci.2024.05.027. Epub 2024 Jun 11.
J Allergy Clin Immunol. 2024.
PMID: 38871183